Westinghouse Electric Company, one of the world’s leading nuclear energy companies, has partnered with the Canadian Nuclear Isotope Council (CNIC), an independent body made up of representatives from the Canadian health sector, nuclear industry and leading research groups, to support the delivery of innovative and lifesaving cancer treatments to people around the world.
The organizations share a commitment to promoting public awareness about the positive use and benefits of medical/industrial isotopes and radiation technologies, working with government stakeholders to ensure that the public policy landscape promotes innovation, and supports the increase of medical and industrial isotope uses.
“Patients fighting cancer and other medical conditions all over the world rely on Canada for the safe and stable supply of medical isotopes,” said James Scongack, Chair of the CNIC. “This presents a major challenge — and opportunity — for Canadian leadership in the training, research, development, deployment and export of medical isotopes for the global market.
“Canada has a unique position that is recognized internationally. It is the world’s largest supplier of Cobalt-60 and Iodine-125, it hosts mostly all supply chain partners within its borders, it has a long tradition in supply chain collaboration, and it is renowned around the world for developing new applications. We need all our partners across the industry to support Canadian isotope leadership, and I am delighted to have the support from Westinghouse, a key component of the Ontario nuclear supply chain.”
“We are pleased to contribute our expertise in the industry to compliment and support CNIC’s efforts to ensure Canada has a reliable and stable supply of critical, nuclear-derived medical isotopes now and into the future,” said Eddie Saab, president, Westinghouse Canada.